Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

A California-based company says it has created the world's first early-stage human egg cells from stem cells using lab-grown ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell.

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

Blind people could one day regain their sight after lab-grown cells restored retinal function in mice, according to a ...

Key Points Interested in Moderna, Inc.? Here are five stocks we like better. Moderna shares rose nearly 20% after Science Day, but the gain is partly attributed to a short squeeze, not fundamentals ...

Blood is always in short supply for transfusions, and patient outcomes in combat, mass casualty and remote situations are seldom favorable.